|
|
Study on the Immune Efficiency for General Vaccine Against Avian Influenza Virus Using Human Mycobacterium Tuberculosis hsp70 as the Carrier for Peptide Epitopes |
ZHENG Qi-sheng,XU Gong-bao,HOU Hong-yan,ZHANG Xue-hua,HOU Ji-bo |
National Research Center of Veterinary Biologicals Engineering and Technology,Jiangsu Academy of Agricultural Sciences,Nanjing 210014,China |
|
|
Abstract M2e gene of three copies for H5N1 subtype AIV was synthesized and fused with human mycobacterium tuberculosis hsp70 gene.The fused gene was cloned into the prokaryotic expression vector to get pET-3M2e and pET-3M2e-hsp70.Recombinant protein r3M2e and r3M2e-hsp70 were successfully expressed induced with IPTG and purified with Ni2+-NTA collumn.Following that,the immunity of the recombinant protein was analysized with Western blot. 20-day-old AIV non-immunized chickens were vaccined with r3M2e and r3M2e hsp70,at the same time,Trx and KLH-M2e inoculated chickens were served as vector and positive controls.Two weeks after the primary vaccination,every group was boosted with the same vaccine as in the primary vaccination.The humoral immunity of the vaccined chickens was evaluated with antibody detection against M2e,cytopathic suppression test,and indirect fluorescence assay.The cellular immunity was estimated according to lymphocyte subtype analysis with flow cytometry and M2e specific cytokine detection.Four weeks after the boost vaccine,all groups were challenged with 100EID50 AIV of H9N2-subtype,and the virus from swabs was detected with Real-time PCR.Results indicated that r3M2e hsp70 vaccined chicken developed the better humoral and cellular immune response,also,made a better performance compared with r3M2e vaccined group in virus challenge.
|
Received: 05 June 2009
Published: 21 December 2009
|
|
|
|
[1] |
Carrat F Flahault.A1 Influenza vaccine : The challenge of antigenic drift.Vaccine,2007,25:6852~6862
|
|
|
[2] |
Palese P1.Making better influenza virus vaccines ?.Emerg Infect Dis,2006,12(1): 61~65
|
|
|
[3] |
David E Swayne.Avian influenza vaccines and therapies for poultry.Comparative Immunology Microbiology and Infectious Diseases,2009,32:351~363
|
|
|
[4] |
TongMing Fu,Daniel C Freed,Melanie S Horton,et al.Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.Virology,2009,385:218~226
|
|
|
[5] |
TongMing Fu,Karen M Grimm,Michael P Citron,et al.Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.Vaccine,2009,27: 1440~1447
|
|
|
[6] |
Adara Y I,Singerb Y R,Levib E Tzehoval, et al.A universal epitopebased influenza vaccine and its efficacy against H5N1.Vaccine,2009,27: 2099~2107
|
|
|
[7] |
Sambrook J,Fritsch E F,Maniatis T.Molecule Coloning.2nd ed Cold Spring Harbor:Cold Spring Harbor Laboratory Press,1989.49~56,845~848,876~887
|
|
|
[8] |
Wanli Liu,Zou Peng,et al.Sequence comparison between the extracellular domain of M2 protein huaman and avian influenza A virus provides new information for bivalent influenza vaccine design.Microbes and Infection,2005,7:171~177
|
|
|
[9] |
Marina De Filette,Willy Min Jou,Ashley Birkett,et al.Universal influenza A vaccine: Optimization of M2based constructs.Virology,2005,337:149~161
|
|
|
[10] |
Asea A,Krneft S K,Jones E A K,et al.Hsp70 stimulates cytokine production through a CD14 dependent pathway,demonstrating its dual role as a chapemne and cytokine.Nature Medicine,2000,11(4): 435~436
|
|
|
[11] |
Udono H,Yamano T,Kawabata Y,et al.Generation of cytototoxic T lymphocytes by MHCⅠligand fused to heat shock protein 70.Inter Immunol,2001,13(10): 1233~1242
|
|
|
[12] |
Haug M,Dannecker L,Schepp C P,et al.The heat shock protein Hsp70 enhances antigenspecific proliferation of human CD4+ memory T cells.Eur J Immunol,2005,35(11): 3163~3172
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|